RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/32210727http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/32210727http://www.w3.org/2000/01/rdf-schema#comment"Objective: The therapeutic effects of the checkpoint kinase 1 (CHK1)-targeted inhibition in tumor therapy have been confirmed, but how to choose an effective application method in breast cancer with heterogeneous molecular characteristics has remained unclear. Methods: We evaluated the status of CHK1 in breast cancer using the cancer genome atlas database. Chemosensitivity and single-agent antitumor activity of CHK1 inhibition were measured by drug sensitivity assay, cell proliferation assay, cell cycle and apoptosis analysis in breast cancer with different ER/PR status. And based on the conjoint transcriptome atlas analyses, the corresponding mechanism were explored. Results: In ER-/PR-/HER2- breast cancer, CHK1 inhibition enhanced adriamycin (ADR) chemosensitivity which was mediated by the mitotic checkpoint complex (MCC)-anaphase-promoting complex/cyclosome (APC/C)-cyclin B1 axis, Msh homeobox 2 (MSX2) and Bcl-2-like protein 11 (BIM). However, in ER+/PR+/HER2- breast cancer, because of the significant suppression for centromere protein F (CENPF)-mediated transcriptional activation of CHK1 induced by ADR itself, CHK1 inhibition fails to sensitize ADR toxicity. Interestingly, CHK1 inhibition showed the single-agent antitumor activity in ER+/PR+/HER2- breast cancer which was mediated by the cyclin dependent kinase inhibitor 1A (p21), kinesin family member 11 (Eg5) and cell surface death receptor (Fas). Conclusions: CHK1's variable role determines the application of CHK1 inhibition in breast cancer with ER/PR heterogeneity."xsd:string
http://purl.uniprot.org/citations/32210727http://purl.org/dc/terms/identifier"doi:10.7150/ijbs.41627"xsd:string
http://purl.uniprot.org/citations/32210727http://purl.uniprot.org/core/author"Chen S."xsd:string
http://purl.uniprot.org/citations/32210727http://purl.uniprot.org/core/author"Guo J."xsd:string
http://purl.uniprot.org/citations/32210727http://purl.uniprot.org/core/author"Liu H."xsd:string
http://purl.uniprot.org/citations/32210727http://purl.uniprot.org/core/author"Liu T."xsd:string
http://purl.uniprot.org/citations/32210727http://purl.uniprot.org/core/author"Wang D."xsd:string
http://purl.uniprot.org/citations/32210727http://purl.uniprot.org/core/author"Xu W."xsd:string
http://purl.uniprot.org/citations/32210727http://purl.uniprot.org/core/author"Zhang H."xsd:string
http://purl.uniprot.org/citations/32210727http://purl.uniprot.org/core/author"Huang M."xsd:string
http://purl.uniprot.org/citations/32210727http://purl.uniprot.org/core/author"Gao P."xsd:string
http://purl.uniprot.org/citations/32210727http://purl.uniprot.org/core/author"Mu K."xsd:string
http://purl.uniprot.org/citations/32210727http://purl.uniprot.org/core/date"2020"xsd:gYear
http://purl.uniprot.org/citations/32210727http://purl.uniprot.org/core/name"Int J Biol Sci"xsd:string
http://purl.uniprot.org/citations/32210727http://purl.uniprot.org/core/pages"1388-1402"xsd:string
http://purl.uniprot.org/citations/32210727http://purl.uniprot.org/core/title"The Role of CHK1 Varies with the Status of Oestrogen-receptor and Progesterone-receptor in the Targeted Therapy for Breast Cancer."xsd:string
http://purl.uniprot.org/citations/32210727http://purl.uniprot.org/core/volume"16"xsd:string
http://purl.uniprot.org/citations/32210727http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/32210727
http://purl.uniprot.org/citations/32210727http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/32210727
http://purl.uniprot.org/uniprot/#_A0A125SXW0-mappedCitation-32210727http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/32210727
http://purl.uniprot.org/uniprot/#_A0A125SXW1-mappedCitation-32210727http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/32210727
http://purl.uniprot.org/uniprot/#_A0A125SXV8-mappedCitation-32210727http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/32210727
http://purl.uniprot.org/uniprot/#_A0A125SXV9-mappedCitation-32210727http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/32210727
http://purl.uniprot.org/uniprot/#_A0A125SXW2-mappedCitation-32210727http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/32210727